Inhibitory Effect of Combination with Korean Red Gnseng and Morus Alba in High Fructose-induced Vascular Inflammation and Steatohepatitis |
Lee, Yun Jung
(College of Oriental Medicine, Wonkwang University)
Yoon, Jung Joo (College of Oriental Medicine, Wonkwang University) Lee, So Min (College of Oriental Medicine, Wonkwang University) Kho, Min Chul (College of Oriental Medicine, Wonkwang University) Kim, Hye Yoom (College of Oriental Medicine, Wonkwang University) Ahn, You Mee (College of Oriental Medicine, Wonkwang University) Kho, Joung Hyun (College of Oriental Medicine, Wonkwang University) Lee, Kee Byoung (College of Oriental Medicine, Sangji University) Lee, Ho Sub (College of Oriental Medicine, Wonkwang University) Choi, Kyung Min (Institute of JinAn Red Ginseng Korea) Kwon, Tae Oh (College of Life Science and Natural Resources, Wonkwang University) Kang, Dae Gill (College of Oriental Medicine, Wonkwang University) |
1 | Fortez, M., Ancellin, N., Andreelli, F., Saintillan, Y., Grondin, P., Kahn, A., Thorens, B., Vaulont, S., Viollet, B. Short-term overexpression of a constitutively active form of AMPK-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes. 54: 1331-1339, 2005. DOI ScienceOn |
2 | Nielsen, S., Guo, Z., Johnson, C.M., Hensrud, D.D., Jensen, M.D. Splanchnic lipolysis in human obesity. J. Clin. Invest. 113: 1582-1588, 2004. DOI |
3 | Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114: 1752-1761, 2004. DOI |
4 | Kwon, K.R., Park, W.P., Kang, W.M., Jeon, E.Y., Jang, J.H. Identification and analysis of differentially expressed genes in mountain cultivated ginseng and mountain wild ginseng. J. Acupunct. Meridian. Stud. 4: 123-128, 2011. DOI ScienceOn |
5 | Liu, C.X., Xiao, P.G. Recent advances on ginseng research in China. J. Ethnopharmacol. 36: 27-38, 1992. DOI ScienceOn |
6 | Kitts, D., Hu, C. Efficacy and safety of ginseng. Public. Health. Nutr. 3: 473-485, 2000. |
7 | Enkhmaa, B., Shiwaku, K., Katsube, T., Kitajima, K., Anuurad, E., Yamasaki, M., Yamane, Y. Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice. J. Nutr. 135: 729-734, 2005. DOI |
8 | Miyahara, C., Miyazawa, M., Satoh, S., Sakai, A., Mizusaki, S. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J. Nutr. Sci. Vitaminol. 50: 161-164, 2004. DOI ScienceOn |
9 | Lee, Y.J., Choi, D.H., Kim, E.J., Kim, H.Y., Kwon, T.O., Kang, D.G., Lee, H.S. Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet. Am. J. Chin. Med. 39: 39-52, 2011. DOI ScienceOn |
10 | Park, S.H., Jeon, W.K., Kim, S.H., Kim, H.J., Park, D.I., Cho, Y.K., Sung, I.K., Sohn, C.I., Keum, D.K., Kim, B.I. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21: 138-143, 2006. DOI ScienceOn |
11 | Elliott, S.S., Keim, N.L., Stern, J.S., Teff, K., Havel, P.J. Fructose, weight gain, and the insulin resistance syndrome. Am. J. Clin. Nutr. 76: 911-922, 2002. DOI |
12 | Hwang, I.S., Ho, H., Hoffman, B.B., Reaven, G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 10: 512-516, 1987. DOI |
13 | Sanchez-Lozada, L.G., Tapia, E., Jimenez, A., Bautista, P., Cristobal, M., Nepomuceno, T., Soto, V., Avila-Casado, C., Nakagawa, T., Johnson, R.J, Herrera-Acosta, J., Franco, M. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am. J. Physiol. Renal. Physiol. 292: 423-429, 2007. |
14 | Feingold, K.R., Grunfeld, C. Role of cytokines in inducing hyperlipidemia. Diabetes. 41: 97-101, 1992. DOI |
15 | Stenvinkel, P., Heimburger, O., Jogestrand, T. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am. J. Kidney. Dis. 39: 274-282, 2002. DOI ScienceOn |
16 | Duprez, D.A., Somasundaram, P.E., Sigurdsson, G., Hoke, L., Florea, N., Cohn, J.N. Relationship between Creactive protein and arterial stiffness in an asymptomatic population. J. Hum. Hypertens. 19: 515-519, 2005. DOI ScienceOn |
17 | Yoon, K.H., Lee, J.H., Kim, J.W., Cho, J.H., Choi, Y.H., Ko, S.H., Zimmet, P., Son, H.Y. Epidemic obesity and type 2 diabetes in Asia. Lancet. 11: 1681-1688, 2006. |
18 | Hommels, M.J, van der Ven A.J.A.M., Kroon, A.A., Kessels, A.G.H., Van Dieijen-Visser, M.P., Van Engelshoven, J.A.M., Bruggeman, C.A., De Leeuw, P.W. C-reactive protein, atherosclerosis and kidney function in hypertensive patients. J. Hum. Hypertens. 19: 521-526, 2005. DOI ScienceOn |
19 | Georg, P., Ludvik, B. Lipids and diabetes. J. Clin. Basic. Cardiol. 3: 159-162, 2000. |
20 | International Diabetes Federation. Diabetes Atlas, 2nd ed, 2003 Available at: www.eatlas.idf.org (accessed on July 12, 2008). |
21 | Tay, S.S., Mc Cormack, A., Rose, M.L. Effect of cognate human CD4+ Tcell and endothelial cell interactions upon chemokine production. Transplantatio.n 78(7):987-994, 2004. DOI ScienceOn |
22 | Uze, G., Pachman, L.M. Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge. Curr. Opin. Rheumatol. 15(6):691-697, 2003. DOI ScienceOn |
23 | Frostegard, J., Wu, R., Haegerstrand, A., patarroyo, M., Lefver,, A.K. Mononuclear leukocytes exposed to oxidized low density lipoprotein secrete a factor that stimulates endothelial cells to express adhesion molecules. Atherosclerosis. 103: 213-219, 1993. DOI ScienceOn |
24 | Mes, Bouhle., M.A., Staels, B., Chinetti-Gbaguid, G. Peroxisome proliferator-activated receptors-from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease. J. Intern. Med. 263(1):28-42, 2008. |
25 | Li, J.J., Zhu, C.G., Yu, B., Liu, Y.X., Yu, M.Y. The role of inflammation in coronary artery calcification. Agening. Res. Rev. 6(4):263-270, 2007. DOI ScienceOn |
26 | Jun, D.W. Non-alcoholic fatty liver disease. Korean J. Hepatol. 17: S332-S336, 2011. |
27 | Matteoni, C.A., Younossi, Z.M., Gramlich, T., Boparai, N., Liu, Y.C., Mc, Cullough, A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116: 1413-1419, 1999. DOI ScienceOn |
28 | Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Rizzetto, M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 123: 134-140, 2002. DOI ScienceOn |
29 | Marrero, J.A., Fontana, R.J., Su, G.L., Conjeevaram, H.S., Emick, D.M., Lok, A.S. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 36: 1349-1354, 2002. DOI |
30 | Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., Rizzetto, M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 37: 917-923, 2003. DOI ScienceOn |
31 | Hong, M.H., Lim, H.K., Park, J.E., Jun, N.J., Lee, Y.J., Cho, M.J., Kim, S.M. The Antihypertensive and Vasodilating Effects of Adventitious Root Extracts of Wild Ginseng. J. Korean. Soc. Appl. Biol. Chem. 51: 102-107, 2008. DOI ScienceOn |
32 | Mizuno, M., Yamada, J., Terai, H., Kozukue, N., Lee, Y.S., Tsuchide, H. Differences in immunomodulating effects between wild and cultured Panax ginseng. Biochem. Biophys. Res. Commun. 200: 1672-1678, 1994. DOI ScienceOn |
33 | Neuschwander-Tetri, B.A., Brunt, E.M., Wehmeier, K.R., Oliver, D., Bacon, B.R. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology. 38: 1008-1017, 2003. DOI |
34 | Quagliaro, L., Piconi, L., Assaloni, R., Da Ros, R., Maier, A., Zuodar, G., Schreyer, S.A., Vick, C., Lystig, T.C., Mystkowski, P., LeBoeuf, R.C. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am. J. Physiol. Endocrinol. Metab. 282: 207-214, 2002. DOI |
35 | Diehl, A.M. Nonalcoholic steatohepatitis. Semin. liver. dis. 19: 220-229, 1999. |
36 | Akyuz, F., Demir, K., Ozdil, S., Aksoy, N., Poturoglu, S., Ibrisim, D., Kaymakoglu, S., Besisik, F., Boztas, G., Cakaloglu, Y., Mungan, Z., Cevikbas, U., Okten, A. The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease. Dig. Dis. Sci. 52:2359-2367, 2007. DOI ScienceOn |
37 | Belfort, R., Harrison, S.A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., Berria, R., Ma, J.Z., Dwivedi, S., Havranek, R., Fincke, C., DeFronzo, R., Bannayan, G.A., Schenker, S., Cusi, K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355: 2297-2307, 2006. DOI ScienceOn |
38 | Promrat, K., Lutchman, G., Uwaifo, G.I., Freedman, R.J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., Liang, T.J., Yanovski, J.A., Kleiner, D.E., Hoofnagle, J.H. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology. 39: 188-196, 2004. DOI ScienceOn |